Australia Asthma Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4186

  • Format: PPT, PDF

Australia Asthma Drugs Market: Segmented by Type (Quick-Relief Medications (Rescue Medication), Medications for Allergy-Induced Asthma, & Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies)- Growth, Trends, And Forecasts (2019 – 2028)



Report Overview

The Australia Asthma Drugs market size stood at USD 474 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Asthma is a chronic lung disease characterized by narrowing of airways and continual, marked inflammation and in response to specific triggers, which are usually reversible. If the management of the conditions is not done properly, this may elevate the risk of Asthma attacks and even medical emergencies. Most, if not all, Asthma attacks are preventable, especially in adults. Notwithstanding this fact, there is a rising prevalence of Asthma, which is closely linked to the severity and mortality of the disease.

Preventive drugs for Asthma play a crucial role in managing the disease conditions and help pacify the risk of Asthma attacks. Drug therapies for Asthma have been evolving rapidly, driven by advances in the pharmacotherapy of Asthma. Research into expanding the various pathophysiologic processes related to Asthmatic response and triggers will lead to advanced classes of Asthma drugs with less toxicity.

Market Drivers

The rise in pollution levels in several industrialized nations has led to an increased presence of allergens triggering Asthma. This is a key factor driving the demand for preventive Asthma drugs. The rising incidence of Asthma in various parts of Australia, along with the morbidity associated with the disease, is a key factor accentuating the demand for preventive drugs. The rise in population with higher tobacco consumption and prolonged exposure to smoke of biomass fuels is adding to the prevalence of the disease.

Asthma Australia welcomes the new GSK Australia once-daily ARNUITY ELLIPTA Asthma treatment soon to be added to the shelves of Australian Pharmacies and listed on the Pharmaceutical Benefits Scheme, announced this week. Asthma Australia is the nation’s peak body representing the 2.7 million Australians with Asthma and with more than 15 Asthma inhalers now on the market it was important for both prescribers and patients to know how ARNUITY ELLIPTA fits in.

The market is majorly driven by increasing drug approvals, High prevalence of ASTHMA/AIDS. The increasing emphasis on the research and development of ASTHMA/AIDS drugs has led to several drug innovations in recent years. The increasing demand for therapeutic procedures and treatment methods has created a subsequent emphasis on the development of related drugs. The rising prevalence of ASTHMA/AIDS has resulted in the increased emphasis on the development of treatment methods and drugs associated with the treatment of this disease. Due to the increasing incidence of ASTHMA/AIDS, the ASTHMA/AIDS drug companies have witnessed massive growth opportunities in recent years.

Epidemiology of ASTHMA

Around 2.7 million Australians (11% of the total population) have Asthma, based on self‑reported data from the 2017–18 Australian Bureau of Statistics (ABS) National Health Survey (NHS) (ABS 2018).


1. Australia Asthma Drugs Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Prevalence of ASTHMA
B. New Asthma Treatments
C. Rise in Population Level
3. Epidemiology of Asthma………………………………………………….
A. Prevalence of ASTHMA cases
B. Incidence of ASTHMA cases
C. Health Expenditure on ASTHMA
4. Asthma Drugs Market Segmentation………………………………………
A. Type
I. Quick-Relief Medications (Rescue Medication)
II. Medications for allergy-induced Asthma
III. Others
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Asthma Drugs Major Drugs Market Share………………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. AstraZeneca plc Company overview, Product & Services, Strategies & Financials
B. Bushranger Ingelheim Company overview, Product & Services, Strategies & Financials
C. F. Hoffmann-La Roche Ltd Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of Asthma Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type:

By Type of Asthma, the Australian market is segmented into Quick-Relief Medications (Rescue Medication), Medications for allergy-induced Asthma, & Others. Asthma quick-relief medicines work fast to control asthma symptoms. Some quick-relief Asthma medicines include Albuterol (ProAir HFA, Proventil HFA, Ventolin HFA), Levalbuterol (Xopenex HFA), Metaproterenol, & Terbutaline. Treatment for Allergy triggered Asthma is Rescue Inhalers (Short-Acting Bronchodilators), Inhaled Corticosteroids, Long-Acting Bronchodilators, Anti-Leukotriene Drugs, Oral Corticosteroids, Antibody Treatment, Immunotherapy, & Alternative Therapies.

By Distribution Channel:

Based on the distribution channel, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital segment is expected to dominate the market throughout the forecast period. The increasing number of clinics is propelling the growth of the specialty clinics segment.

Major Players

Top drug makers are making sizeable investments in clinical trials focused on reducing Asthma exacerbations, in a move to develop advanced and more efficacious drugs for managing Asthma. Players holding a position of prominence in the preventive Asthma drugs market include Mylan N.V., Abbott Laboratories, Bushranger Ingelheim, F. Hoffmann-La Roche, Merck & Co., AstraZeneca plc, GlaxoSmithKline plc, and Novartis AG.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements